Cadila Pharma launches esomeprazole tablets in India

Esiloc will be 50 per cent more economical, thus making it a superior yet affordable choice

250
Cadila Pharma launches esomeprazole tablets in India

Ahmedabad-based Cadila Pharmaceuticals has announced the launch of esomeprazole tablets for the treatment of hyperacidity and drug-induced gastritis under the brand name Esiloc.

“Esiloc will be 50 per cent more economical, thus making it a superior yet affordable choice. It will be made available in 20 mg and 40 mg tablets,” informed the company through a statement.

Also read: Cipla launches generic version of remdesivir at Rs 4,000 per vial

Esomeprazole, a proton pump inhibitor (PPI), acts on the luminal surface of gastric parietal cells, resulting in inhibition of acid secretion. Esomeprazole provides higher rates of healing of erosive gastro-oesophageal reflux (GERD) and sustained resolution of heartburn in patients.

GERD, if untreated, can lead to conditions like peptic ulcer, chest pain, oesophagus cancer and other fatal conditions.

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.